3288 results for «2026年3月25日511010收益情况»

Filter By

3288 results

Shock and PCI: due to ECMO I survived

22 May 2025 – From EuroPCR 2025

Explore life-saving strategies in the management of cardiogenic shock complicating PCI, with emphasis on ECMO utilization. This session reviews challenging cardiac arrest cases, multi-culprit STEMI scenarios, and innovative STEMI treatments in critical patients, illustrating how ECMO support can be pivotal in survival and recovery.

Shock and PCI: due to ECMO I survived

Management of complex left main trifurcation lesion

22 May 2025 – From EuroPCR 2025

This session focuses on the management of complex left main trifurcation lesions. Review hybrid and double TAP techniques, long-term follow-up outcomes, and innovative approaches such as the inverted double TAP technique, offering insights into optimizing treatment strategies for these challenging anatomical scenarios.

Management of complex left main trifurcation lesion

Pharmacotherapy coronary interventions: new insights

22 May 2025 – From EuroPCR 2025

Stay abreast of new insights in pharmacotherapy for coronary interventions with a focus on optimizing patient outcomes. Topics include ticagrelor monotherapy in chronic coronary syndrome post-PCI, analysis of multiple events in high bleeding risk patients from the MASTER DAPT trial, effects of beta-blocker interruption in MI...

Pharmacotherapy coronary interventions: new insights

Challenging tricuspid TEER cases

22 May 2025 – From EuroPCR 2025

Explore challenging tricuspid transcatheter edge-to-edge repair (TEER) cases highlighting combined LAA occlusion and mitral valve repair, anatomical complexities, and strategies to complete surgical interventions percutaneously. Discuss the balance between procedural perfection and clinical practicality in complex valve anatomies.

Challenging tricuspid TEER cases

Troubleshooting and management communication in LAA closure

22 May 2025 – From EuroPCR 2025

This session provides comprehensive guidance on troubleshooting and communication during left atrial appendage (LAA) closure procedures. Covering device migration management, transeptal puncture in high bleeding risk patients, scoliosis adaptations, and advanced catheter techniques, it emphasizes practical solutions for procedural complications.

Troubleshooting and management communication in LAA closure

Clinical impact of mechanical circulatory support

22 May 2025 – From EuroPCR 2025

Explore the clinical impact of mechanical circulatory support through a series of detailed presentations covering protocols and training effects on outcomes in left-sided micro-axial flow-supported shock patients, practice variations between Sweden and the U.S., six-month outcomes post coronary intervention with VA-ECMO, and the prognostic value of...

Clinical impact of mechanical circulatory support

ACS management: when imaging matters

22 May 2025 – From EuroPCR 2025

This session focuses on the critical role of intracoronary imaging in acute coronary syndrome (ACS) management. Topics include spontaneous coronary artery dissection (SCAD) cases, the utilization of IVUS and cardiac CT in emergent PCI during cardiogenic shock, and the assessment of non-culprit lesions using OCT to...

ACS management: when imaging matters

Antiplatelet strategies for clinical dilemmas

22 May 2025 – From EuroPCR 2025

Dive into the complexities of antiplatelet strategies tailored for challenging clinical scenarios. This session covers antiplatelet therapy in myocardial bridge, bleeding risk reduction via ticagrelor removal before urgent CABG, peri-procedural management for patients on oral anticoagulants undergoing PCI, and the use of cangrelor in out-of-hospital cardiac...

Antiplatelet strategies for clinical dilemmas

When angina cannot be cured with stents: what are the remaining options

22 May 2025 – From EuroPCR 2025

Explore therapeutic options for patients with angina refractory to stenting. This session reviews the efficacy and clinical outcomes of coronary sinus (CS) reducer implantation for microvascular dysfunction, factors influencing procedural success, next-generation CS reducer innovations, and the role of aspirin in angina without obstructive coronary disease.

When angina cannot be cured with stents: what are the remaining options

How to address the problem of calcified left main lesions

22 May 2025 – From EuroPCR 2025

Gain expert perspectives on addressing calcified left main coronary lesions in high-risk and complex clinical scenarios. This session features challenging cases including ACS patients with reduced LVEF, severe calcified stenosis of left main bifurcation, complex PCI in post-CABG octogenarians with rotablation under Impella support, and other...

How to address the problem of calcified left main lesions

Electrosurgical techniques in transcatheter mitral valve replacement

22 May 2025 – From EuroPCR 2025

Delve into electrosurgical techniques in transcatheter mitral valve replacement. This session covers advanced methods including the tip-to-base lampoon technique, electrosurgical laceration of failed devices, left ventricular outflow tract obstruction management, combined septal ablation and valve-in-valve procedures, and management of severe aortic regurgitation post-laceration.

Electrosurgical techniques in transcatheter mitral valve replacement

Management of challenging TAVI device delivery

22 May 2025 – From EuroPCR 2025

Explore innovative solutions for managing challenging TAVI device delivery. This session presents cases involving kinked and stuck Navitor valves, the use of snare devices for retrieval, balloon-expandable TAVI in severe bicuspid aortic stenosis, and alternative access routes such as transaortic access after failed transfemoral valve-in-valve procedures.

Management of challenging TAVI device delivery

Calcified un-dilatable lesions in ACS: what should I do?

22 May 2025 – From EuroPCR 2025

Address the challenges of severely calcified undilatable lesions during acute coronary syndrome PCI. This session reviews the impact of coronary calcification on PCI strategy, highlights pitfalls in lesion preparation, and presents detailed case studies demonstrating effective treatment approaches.

Calcified un-dilatable lesions in ACS: what should I do?

Innovation to address unmet clinical needs in transcatheter valve therapies

22 May 2025 – From EuroPCR 2025

Discover innovations addressing unmet clinical needs in transcatheter valve therapies. This session shares case-based experiences including young aortic stenosis patients, mitral regurgitation with annular calcification, and severe tricuspid regurgitation with right ventricular dysfunction, alongside the latest advances in TAVI, TMVR, and tricuspid interventions.

Innovation to address unmet clinical needs in transcatheter valve therapies

Optimal use of cardiac imaging to plan and guide transcatheter LAA closure

22 May 2025 – From EuroPCR 2025

Optimize left atrial appendage (LAA) closure outcomes through expert use of cardiac imaging. This session details the role of various imaging modalities in pre-procedural planning, intraprocedural guidance, and post-procedural assessment. Gain practical insights on transesophageal echocardiography, computed tomography, intracardiac echocardiography, and their integration to enhance procedural...

Optimal use of cardiac imaging to plan and guide transcatheter LAA closure

What an interventional cardiologist should know about anti-thrombotics

22 May 2025 – From EuroPCR 2025

This session provides comprehensive knowledge on anti-thrombotic management for interventional cardiologists, emphasizing effective inhibition during acute STEMI, latest evidence implementation for high bleeding risk patients, and customization of dual antiplatelet therapy in patients with high thrombotic and low bleeding risks through clinical cases and evidence-based recommendations.

What an interventional cardiologist should know about anti-thrombotics

TAVI outcomes

22 May 2025 – From EuroPCR 2025

Examine contemporary outcomes of transcatheter aortic valve implantation (TAVI) across diverse patient populations and device generations. This session presents data on severe aortic stenosis stratified by resting gradient, comparisons between bicuspid and tricuspid valve stenosis, and clinical results of intra-annular versus supra-annular devices, including two-year outcomes...

TAVI outcomes

Procedural planning and risk stratification in multivessel PCI

22 May 2025 – From EuroPCR 2025

This session focuses on procedural planning and risk stratification in multivessel PCI, presenting data from the TALENT and FIRE trials, prognostic value of post-PCI physiological assessments, and an innovative study comparing large language models in managing complex interventional cardiology cases.

Procedural planning and risk stratification in multivessel PCI

Coronary physiology: FFR and beyond

22 May 2025 – From EuroPCR 2025

Advance your understanding of coronary physiology with a focus on fractional flow reserve (FFR) and beyond. This session covers randomized trials comparing physiology-guided treatment to standard care in ANOCA, graft patency related to quantitative flow ratio, impacts of microvascular dysfunction on patient outcomes, and prognostic value...

Coronary physiology: FFR and beyond

What did we learn from my TAVI complications?

22 May 2025 – From EuroPCR 2025

Review critical lessons from TAVI complications, focusing on early identification and management of access site issues and acute coronary obstruction. Learn effective preventive actions and procedural strategies to minimize severe TAVI-related complications through detailed case discussions.

What did we learn from my TAVI complications?
Didn’t find what you were looking for?